TaiMed Biologics (Taiwan) Insiders
| 4147 Stock | TWD 96.40 0.60 0.63% |
TaiMed Biologics employs about 37 people. The company is managed by 17 executives with a total tenure of roughly 115 years, averaging almost 6.0 years of service per executive, having 2.18 employees per reported executive. Recap of TaiMed Biologics' management performance can provide insight into the venture performance.
| James Chang Chairman Chairman of the Board, Chief Executive Officer |
| ChiChuan Chen Chairman Chairman of the Board |
TaiMed |
TaiMed Biologics Management Team Effectiveness
The company has return on total asset (ROA) of (0.062) % which means that it has lost $0.062 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1766) %, meaning that it generated substantial loss on money invested by shareholders. TaiMed Biologics' management efficiency ratios could be used to measure how well TaiMed Biologics manages its routine affairs as well as how well it operates its assets and liabilities.TaiMed Biologics Workforce Comparison
TaiMed Biologics is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 175. TaiMed Biologics totals roughly 37.0 in number of employees claiming about 21% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.7) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.47) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.47. TaiMed Biologics Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. TaiMed Biologics Price Series Summation is a cross summation of TaiMed Biologics price series and its benchmark/peer.
TaiMed Biologics Notable Stakeholders
A TaiMed Biologics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as TaiMed Biologics often face trade-offs trying to please all of them. TaiMed Biologics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting TaiMed Biologics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| James Chang | Chairman of the Board, Chief Executive Officer | Profile | |
| ChiChuan Chen | Chairman of the Board | Profile | |
| Jack Chen | Chief Financial Officer | Profile | |
| ChinMing Chang | Chief Technology Officer | Profile | |
| MingChing Chen | Independent Director | Profile | |
| LungYeh Cho | Director | Profile | |
| LuPing Chow | Director | Profile | |
| Howard Lee | Independent Director | Profile | |
| Tamon Tseng | Director | Profile | |
| IngWen Tsai | CoFounder | Profile | |
| GwoFong Lin | Independent Director | Profile | |
| TaiHorng Young | Director | Profile | |
| TienChieh Lee | Director | Profile | |
| LanBo Chen | CoFounder | Profile | |
| Qiankun Lin | Director | Profile | |
| Hui Zheng | Head Department | Profile | |
| David MD | Chief CoFounder | Profile |
About TaiMed Biologics Management Performance
The success or failure of an entity such as TaiMed Biologics often depends on how effective the management is. TaiMed Biologics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of TaiMed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the TaiMed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
TaiMed Biologics Inc., a biotechnology company, develops health-care products. The company was founded in 2007 and is based in Taipei City, Taiwan. TAIMED BIOLOGICS operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange.
Please note, the imprecision that can be found in TaiMed Biologics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of TaiMed Biologics. Check TaiMed Biologics' Beneish M Score to see the likelihood of TaiMed Biologics' management manipulating its earnings.
TaiMed Biologics Workforce Analysis
Traditionally, organizations such as TaiMed Biologics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare TaiMed Biologics within its industry.TaiMed Biologics Manpower Efficiency
Return on TaiMed Biologics Manpower
| Revenue Per Employee | 11.2M | |
| Revenue Per Executive | 24.3M | |
| Net Loss Per Employee | 12.7M | |
| Net Loss Per Executive | 27.7M |
Additional Tools for TaiMed Stock Analysis
When running TaiMed Biologics' price analysis, check to measure TaiMed Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TaiMed Biologics is operating at the current time. Most of TaiMed Biologics' value examination focuses on studying past and present price action to predict the probability of TaiMed Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TaiMed Biologics' price. Additionally, you may evaluate how the addition of TaiMed Biologics to your portfolios can decrease your overall portfolio volatility.